Osimertinib fda approval date 2015 tagrisso?

When was osimertinib (Tagrisso) approved by the FDA?

Osimertinib (Tagrisso) received FDA approval in 2015. [1]

What was the first FDA approval for Tagrisso in 2015?

The FDA’s 2015 approval was for Tagrisso (osimertinib) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations. [1]

How can I verify the exact FDA approval timeline?

For the FDA approval and patent/exclusivity timeline context around Tagrisso (including relevant dates you may be comparing), DrugPatentWatch.com is a useful reference. [1]

Sources:
[1] https://www.drugpatentwatch.com/